Skip to main content

Table 1 Main characteristics of the studies included in the systematic review and meta-analysis on the disclosure of HIV/AIDS status to infected children, 1985–2021

From: Prevalence, socio-demographics and service use determinants associated with disclosure of HIV/AIDS status to infected children: a systematic review and meta-analysis by 1985–2021

Author

Sample size

Year of publish

Year of implementation

Design

Quality of the evidence

Socio-demographic determinants

Service use determinants

Child aged higher than 10 years

Primary or lower schooling level

Having a non-biological parents

Higher social support

Primary education of caregivers

Medication adherence (ART therapy)

Hospital follow-up

Time since diagnosis of 5 years or more

Duration of ART more than 5 years

Appiah et al. [1]

180

2021

2017–2018

Cross-section

Good

     

*

   

Abegaz et al. [2]

449

2019

2018

Cross-section

Satisfactory

*

   

*

 

*

*

 

Alemu et al. [3]

231

2013

2013

Cross-section

Good

       

*

 

Lencha et al. [4]

200

2018

2018

Cross-section

Good

   

*

     

Negese et al. [5]

428

2012

2012

Cross-section

Good

  

*

      

Meena et al. [6]

144

2018

2015–2017

Cross-section

Satisfactory

         

Bajaria et al. [7]

10,673

2020

2018–2019

Cross-section

Satisfactory

 

*

  

*

    

Bulali et al. [8]

39

2018

2017

Cross-section

Good

 

*

   

*

   

Namasopo-Oleja et al. [9]

174

2015

2009

Cross-section

Very Good

*

  

*

 

*

   

Atwiine et al. [10]

312

2015

2012

Cross-section

Good

         

Mengesha et al. [11]

325

2018

2016

Cross-section

Good

         

Vreeman et al. [12]

285

2015

2013

Cross-section

Very Good

         

Paintsil et al. [13]

446

2020

2013–2016

Cross-section

Good

    

*

    

Cluver et al. [14]

1102

2015

2015

Cross-section

Good

         

Nzota et al. [15]

334

2015

2011–2012

Cross-section

Good

*

        

Ayele et al. [16]

374

2021

2019

Cross-section

Very Good

*

  

*

     

Tamir et al. [17]

300

2015

2005

Cross-section

Very Good

     

*

  

*

Bhattacharya et al. [18]

145

2011

2010

Cross-section

Very Good

 

*

*

 

*

*

 

*

 

Okechukwu et al. [19]

218

2017

2018

Cross-section

Good

*

        

Guta et al. [20]

221

2020

2019

Cross-section

Satisfactory

*

       

*

van Elsland et al. [21]

190

2019

2012–2013

Cross-section

Good

*

        

Madiba et al. [22]

218

2013

2009–2010

Cross-section

Good

*

 

*

      

Shallo and Tassew [23].

247

2020

2019

Cross-section

Very Good

         

Finnegan et al. [24]

372

2019

2019

Cross-section

Very Good

 

*

       

Kallem et al. [25]

71

2011

2009

Cross-section

Good

*

      

*

*

Madiba and Mokgatle [26].

405

2013

2017

Cross-section

Good

    

*

    

Danjuma et al. [27]

160

2021

2017

Cross-section

Satisfactory

*

        

John-Stewart et al. [28]

271

2013

2006–2007

Cross-section

Good

         

Murnane et al. [29]

553

2017

2013–2014

Cross-section

Good

         

Odiachi and Abegunde [30].

110

2015

2015

Cross-section

Good

*

        

Beima-Sofie et al. [31]

314

2017

2013

Cross-section

Very Good

         

Tucho et al. [32]

327

2021

2020

Cross-section

Good

*

     

*

 

*

Biadgilign et al. [33]

390

2008

2011

Cross-section

Very Good

*

     

*

  

Vreeman et al. [34]

792

2014

2011–2012

Cross-section

Very Good

*

    

*

   

Tadesse et al. [35]

177

2015

2015

Cross-section

Good

*

    

*

 

*

 

Kalembo et al. [36]

429

2019

2015

Cross-section

Good

*

        

Sirikum et al. [37]

260

2014

2014

Cross-section

Good

*

        
  1. *: Variables that are included in the meta-analysis